SAMD4B and breast carcinoma: To evaluate the potential prognostic relevance of SAMD4B in breast cancer, we performed the Kaplan–Meier survival analysis using multiple databases, including Kaplan–Meier Plotter, UALCAN, GEPIA, and OncoDB.